These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23181222)

  • 21. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin.
    Jaichander P; Selvarajan K; Garelnabi M; Parthasarathy S
    J Lipid Res; 2008 Oct; 49(10):2142-8. PubMed ID: 18519978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of polyphenols and polyphenol-rich foods in the modulation of PON1 activity and expression.
    Martini D; Del Bo' C; Porrini M; Ciappellano S; Riso P
    J Nutr Biochem; 2017 Oct; 48():1-8. PubMed ID: 28623808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting paraoxonase-1 in atherosclerosis.
    Mackness M; Mackness B
    Expert Opin Ther Targets; 2013 Jul; 17(7):829-37. PubMed ID: 23573876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1.
    Deakin SP; James RW
    Clin Sci (Lond); 2004 Nov; 107(5):435-47. PubMed ID: 15265000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does paraoxonase play a role in susceptibility to cardiovascular disease?
    Aviram M
    Mol Med Today; 1999 Sep; 5(9):381-6. PubMed ID: 10462749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraoxonase 1 and homocysteine metabolism.
    Perła-Kaján J; Jakubowski H
    Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
    Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.
    Ombres D; Pannitteri G; Montali A; Candeloro A; Seccareccia F; Campagna F; Cantini R; Campa PP; Ricci G; Arca M
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1611-6. PubMed ID: 9763534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation.
    Tajbakhsh A; Rezaee M; Rivandi M; Forouzanfar F; Afzaljavan F; Pasdar A
    Clin Biochem; 2017 Dec; 50(18):1298-1305. PubMed ID: 28779954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses.
    Laplaud PM; Dantoine T; Chapman MJ
    Clin Chem Lab Med; 1998 Jun; 36(7):431-41. PubMed ID: 9746266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells.
    Osaki F; Ikeda Y; Suehiro T; Ota K; Tsuzura S; Arii K; Kumon Y; Hashimoto K
    Atherosclerosis; 2004 Oct; 176(2):279-87. PubMed ID: 15380450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of paraoxonase 1 and lipid profile in healthy children.
    Sumegová K; Nagyová Z; Waczulíková I; Zitnanová I; Duracková Z
    Physiol Res; 2007; 56(3):351-357. PubMed ID: 16792468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans.
    Kim NS; Kang K; Cha MH; Kang BJ; Moon J; Kang BK; Yu BC; Kim YS; Choi SM; Bang OS
    Biochem Biophys Res Commun; 2007 Dec; 364(1):157-62. PubMed ID: 17936248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of Paraoxonase1, Arylesterase and Lipid Profile in Ischemic Stroke Patients.
    Chawhan SS; Mogarekar MR; Wagh RV; Das RR; Pramanik SS; Sonune SM; Chawhan SM
    J Clin Diagn Res; 2015 Nov; 9(11):BC01-3. PubMed ID: 26673997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonase 1 and atherosclerosis-related diseases.
    Kotur-Stevuljević J; Vekić J; Stefanović A; Zeljković A; Ninić A; Ivanišević J; Miljković M; Sopić M; Munjas J; Mihajlović M; Spasić S; Jelić-Ivanović Z; Spasojević-Kalimanovska V
    Biofactors; 2020 Mar; 46(2):193-205. PubMed ID: 31400246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.
    Soran H; Schofield JD; Liu Y; Durrington PN
    Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.